BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vivarelli S, Falzone L, Leonardi GC, Salmeri M, Libra M. Novel insights on gut microbiota manipulation and immune checkpoint inhibition in cancer (Review). Int J Oncol 2021;59:75. [PMID: 34396439 DOI: 10.3892/ijo.2021.5255] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen Y, Yeh Y, Su Y, Liao C, Huang C, Cheng Y, Jan J. Cell adhesion inhibiting peptides exhibit potent anticancer activity and modulate intestinal microbiota. Materials & Design 2022;224:111303. [DOI: 10.1016/j.matdes.2022.111303] [Reference Citation Analysis]
2 Tripathy S, Alvarez N, Jaiswal S, Williams R, Al-khadimi M, Hackman S, Phillips W, Kaur S, Cervantez S, Kelly W, Taverna J. Hypermetabolic lymphadenopathy following the administration of COVID-19 vaccine and immunotherapy in a lung cancer patient: a case report. J Med Case Reports 2022;16:445. [DOI: 10.1186/s13256-022-03660-9] [Reference Citation Analysis]
3 Dahl EK, Abed OK, Kjeldsen J, Donia M, Svane IM, Dige A, Agnholt JS, Bjerrum JT, Seidelin JB. Safety and efficacy of infliximab and corticosteroid therapy in checkpoint inhibitor-induced colitis. Aliment Pharmacol Ther 2022. [PMID: 36123319 DOI: 10.1111/apt.17201] [Reference Citation Analysis]
4 Kim S, Kim Y, Lee S, Kim Y, Jeon B, Kim H, Park H. Live Biotherapeutic Lactococcus lactis GEN3013 Enhances Antitumor Efficacy of Cancer Treatment via Modulation of Cancer Progression and Immune System. Cancers 2022;14:4083. [DOI: 10.3390/cancers14174083] [Reference Citation Analysis]
5 Zhang X, Li H, Lv X, Hu L, Li W, Zi M, He Y. Impact of Diets on Response to Immune Checkpoint Inhibitors (ICIs) Therapy against Tumors. Life 2022;12:409. [DOI: 10.3390/life12030409] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Li Y, Ye Z, Zhu J, Fang S, Meng L, Zhou C. Effects of Gut Microbiota on Host Adaptive Immunity Under Immune Homeostasis and Tumor Pathology State. Front Immunol 2022;13:844335. [DOI: 10.3389/fimmu.2022.844335] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lerner A, Benzvi C. Checkpoint Inhibitors and Induction of Celiac Disease-like Condition. Biomedicines 2022;10:609. [DOI: 10.3390/biomedicines10030609] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Russo E, Boem F, Curini L, Amedei A. Gastrointestinal Cancers: What Is the Real Board of Microenvironment and the Role of Microbiota–Immunity Axis? Interdisciplinary Cancer Research 2022. [DOI: 10.1007/16833_2022_6] [Reference Citation Analysis]
9 Wang Y, Ku W, Liu C, Cheng Y, Chien C, Chang K, Huang C. Supplementation of Probiotic Butyricicoccus pullicaecorum Mediates Anticancer Effect on Bladder Urothelial Cells by Regulating Butyrate-Responsive Molecular Signatures. Diagnostics 2021;11:2270. [DOI: 10.3390/diagnostics11122270] [Reference Citation Analysis]
10 Xuan DTM, Wu CC, Kao TJ, Ta HDK, Anuraga G, Andriani V, Athoillah M, Chiao CC, Wu YF, Lee KH, Wang CY, Chuang JY. Prognostic and immune infiltration signatures of proteasome 26S subunit, non-ATPase (PSMD) family genes in breast cancer patients. Aging (Albany NY) 2021;13:24882-913. [PMID: 34839279 DOI: 10.18632/aging.203722] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]